查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1942524

2026年全球心臟基因檢測市場報告

Cardiogenomics Testing Panels Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，心臟基因組檢測市場發展迅速，預計將從2025年的15.5億美元成長到2026年的17.5億美元，複合年成長率達12.6%。過去幾年的成長可歸因於多種因素，例如心血管疾病盛行率的上升、基因檢測的普及程度有限、人們對遺傳性心臟疾病的認知不斷提高、傳統心血管診斷技術的廣泛應用以及早期定序技術的高成本。

預計未來幾年，心臟基因組檢測市場將快速成長，到2030年市場規模將達到27.8億美元，複合年成長率（CAGR）為12.3%。預測期內的成長要素包括：次世代定序（NGS）技術的進步、人工智慧和生物資訊學在診斷領域的融合、政府對精準醫療的支持措施、多基因和全EXOME顯子組檢測的日益普及，以及對個人化心血管照護需求的不斷成長。預測期內的主要趨勢包括：個人化基因風險評估、人工智慧驅動的診斷工具、遠端心電圖診斷和監測、多基因檢測的整合以及先進的生物資訊平台。

遺傳性心血管疾病盛行率的上升預計將推動心臟基因組檢測市場的成長。遺傳性心血管疾病（ICD）是指由父母遺傳給子女的心臟和血管疾病。基因檢測和診斷技術的進步使得以往難以識別的疾病能夠被更準確地檢測出來，從而促進了確診病例的增加。心臟基因組檢測可以分析導致遺傳性心臟病的基因突變，從而支持早期診斷、風險評估和製定個人化治療方案。例如，根據英國社區健康中心聯合策略需求評估機構（Joint Strategic Needs Assessment）於2025年2月發布的報告，布萊克浦2023年記錄的心血管疾病死亡人數為185人，高於2022年的178人。這一成長趨勢正在推動心臟基因組檢測市場的擴張。

預計未來幾年，不斷成長的醫療費用支出將推動心臟基因組檢測市場的發展。醫療保健支出是指政府、私人機構和個人用於提供、維護和改善醫療保健服務的總資源，包括資金。醫療保健支出成長的主要原因是需要長期治療、持續監測和專業醫療介入的慢性病數量增加。這些支出為心臟基因組檢測提供了支持，用於進行先進的基因分析，從而能夠早期發現和預防遺傳性心血管疾病，改善患者預後並降低長期成本。例如，根據英國國家統計局2024年5月發布的報告，預計2023年醫療保健總支出名目值將增加5.6%，較2022年下降0.9%。因此，不斷成長的醫療保健支出正在推動心血管基因組檢測市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球心臟基因檢測市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 人工智慧（AI）和自主人工智慧
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 個人化基因風險分析
    • 人工智慧驅動的診斷工具
    • 遠距心臟病學和遠端監測
    • 多基因面板整合
    • 高級生物資訊平台

第5章 終端用戶產業市場分析

  • 醫院和診所
  • 診斷檢查室
  • 學術研究機構
  • 心臟病中心
  • 專業基因檢測中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球心臟基因檢測市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球心臟基因檢測市場規模、比較及成長率分析
  • 全球心臟基因檢測市場表現：規模與成長，2020-2025年
  • 全球心臟基因檢測市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場總量（TAM）

第9章 市場細分

  • 依產品類型
  • 單基因panel、多基因panel和全EXOME顯子定序panel
  • 透過技術
  • 次世代定序、基於PCR的檢測、微陣列和其他技術
  • 透過使用
  • 遺傳性心血管疾病、心律不整、心肌病、先天性心臟疾病及其他應用
  • 最終用戶
  • 醫院/診所、診斷檢查室、學術研究機構和其他最終用戶
  • 按類型細分：單基因檢測
  • 離子通道基因檢測、結構性心臟疾病基因檢測、心律不整基因檢測
  • 按類型細分：多基因檢測
  • 心肌病篩檢、心律不整篩檢、先天性心臟疾病篩檢
  • 按類型細分：全EXOME定序panel
  • 標靶心血管EXOME定序、綜合EXOME定序與研究性EXOME子定序

第10章 區域與國家分析

  • 全球心臟基因檢測市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球心臟基因檢測市場：依國家、市場表現及預測（2020-2025年、2025-2030年預測、2035年預測）

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 心臟基因檢測市場：競爭格局及市場佔有率（2024年）
  • 心臟基因檢測市場：公司估值矩陣
  • 心臟基因檢測市場：公司概況
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific, Inc.
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Eurofins Scientific SE

第37章：其他領先和創新企業

  • Illumina Inc., Actia Group, Invitae Corporation, Fulgent Genetics Inc., GeneDx Inc., Ambry Genetics Corporation, Helix OpCo Inc., Centogene Gmbh, Blueprint Genetics Inc., Strand Life Sciences Pvt. Ltd., Genes2Me Pvt. Ltd., BioAro Inc., GENinCode Plc, Igenomix SL, Asper Biotech Ltd.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年心臟基因檢測市場：提供新機會的國家
  • 2030年心臟基因檢測市場：新興細分市場機會
  • 2030年心臟基因檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MCTPE01_G26Q1

Cardiogenomics testing panels are genetic tests that examine multiple genes to determine inherited risks for cardiovascular diseases, including cardiomyopathies, arrhythmias, and familial hypercholesterolemia. They support early diagnosis, personalized treatment, and assessment of family risk.

The primary product types of cardiogenomics testing panels are single-gene panels, multi-gene panels, and whole exome sequencing panels. Single-gene panels test a specific gene to detect mutations or variants linked to a particular inherited condition or disease. The technologies employed include next-generation sequencing, PCR-based testing, microarrays, and others. These panels are applied in areas such as inherited cardiovascular diseases, arrhythmias, cardiomyopathies, congenital heart diseases, and others, and are used by hospitals and clinics, diagnostic laboratories, academic and research institutions, and other end users.

Tariffs are impacting the cardiogenomics testing panels market by increasing the cost of importing sequencing instruments, reagents, and consumables, particularly impacting regions such as North America, Europe, and Asia-Pacific where most advanced equipment is sourced from specialized suppliers. The resulting cost increase has slowed adoption in smaller diagnostic labs, while larger hospitals and academic institutes have mitigated the effect through local sourcing or partnerships. Positive impacts include incentivizing domestic manufacturing of certain testing kits and consumables, potentially reducing future dependency on imports and lowering costs over time.

The cardiogenomics testing panels market research report is one of a series of new reports from The Business Research Company that provides cardiogenomics testing panels market statistics, including cardiogenomics testing panels industry global market size, regional shares, competitors with a cardiogenomics testing panels market share, detailed cardiogenomics testing panels market segments, market trends and opportunities, and any further data you may need to thrive in the cardiogenomics testing panels industry. This cardiogenomics testing panels market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiogenomics testing panels market size has grown rapidly in recent years. It will grow from $1.55 billion in 2025 to $1.75 billion in 2026 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, limited access to genetic testing, increasing awareness of inherited cardiac disorders, adoption of conventional cardiovascular diagnostic techniques, high cost of early sequencing technologies.

The cardiogenomics testing panels market size is expected to see rapid growth in the next few years. It will grow to $2.78 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to advancements in next-generation sequencing (NGS), integration of ai and bioinformatics in diagnostics, government initiatives supporting precision medicine, growing adoption of multi-gene and whole exome panels, increasing demand for personalized cardiovascular care. Major trends in the forecast period include personalized genetic risk profiling, ai-driven diagnostic tools, tele-cardiology and remote monitoring, integration of multi-gene panels, advanced bioinformatics platforms.

The rising prevalence of inherited cardiovascular diseases is expected to drive growth in the cardiogenomics testing panels market. Inherited cardiovascular diseases (ICDs) include heart and blood vessel disorders passed down genetically from parents to offspring. Advances in genetic testing and diagnostics have contributed to an increase in diagnosed cases by enabling more precise detection of previously unidentified conditions. Cardiogenomics testing panels assist in inherited cardiovascular diseases by analyzing genetic mutations responsible for hereditary heart disorders, facilitating early diagnosis, risk evaluation, and personalized treatment plans. For example, in February 2025, the Joint Strategic Needs Assessment, a UK community health center, reported that Blackpool recorded 185 cardiovascular disease deaths in 2023 compared to 178 in 2022. This growing prevalence is fueling expansion in the cardiogenomics testing panels market.

The rising healthcare expenditure is anticipated to drive the expansion of the cardiogenomics testing panels market in the coming years. Healthcare expenditure encompasses the total resources, including funds spent by governments, private entities, and individuals, on providing, maintaining, and enhancing health services and medical care. The increase in healthcare spending is primarily attributed to the growing prevalence of chronic diseases that demand long-term treatment, continuous monitoring, and specialized medical interventions. This expenditure supports cardiogenomics testing panels by financing advanced genetic analyses that allow for the early detection and prevention of inherited cardiovascular diseases, thereby improving patient outcomes and lowering long-term costs. For example, in May 2024, the Office for National Statistics, a UK government department, reported that total healthcare expenditure rose by 5.6% in nominal terms in 2023, marking a 0.9% growth compared to 2022. Consequently, the rising healthcare expenditure fuels the growth of the cardiogenomics testing panels market.

In May 2025, GeneDx Inc., a US-based genetic testing company, completed the acquisition of Fabric Genomics Inc. for an undisclosed sum. Through this acquisition, GeneDx intends to enhance its genomic interpretation capabilities by incorporating Fabric Genomics' AI-powered variant interpretation platform, boosting scalability and diagnostic insights across its testing services. Fabric Genomics, Inc., a US-based genomics and bioinformatics firm, focuses on cardiogenomics testing panels and clinical genetic variant interpretation.

Major companies operating in the cardiogenomics testing panels market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Illumina Inc., Actia Group, Invitae Corporation, Fulgent Genetics Inc., GeneDx Inc., Ambry Genetics Corporation, Helix OpCo Inc., Centogene Gmbh, Blueprint Genetics Inc., Strand Life Sciences Pvt. Ltd., Genes2Me Pvt. Ltd., BioAro Inc., GENinCode Plc, Igenomix S.L., Asper Biotech Ltd.

North America was the largest region in the cardiogenomics testing panels market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiogenomics testing panels market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiogenomics testing panels market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cardiogenomics testing panels market consists of revenues earned by entities by providing services such as genetic risk assessment, early diagnosis, and personalized treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiogenomics testing panels market also includes sales of comprehensive cardiomyopathy panels, cardiac arrhythmia panels, and direct-to-consumer genomic profiles. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiogenomics Testing Panels Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cardiogenomics testing panels market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiogenomics testing panels ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiogenomics testing panels market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Single-Gene Panels; Multi-Gene Panels; Whole Exome Sequencing Panels
  • 2) By Technology: Next-Generation Sequencing; PCR-Based Testing; Microarray; Other Technologies
  • 3) By Application: Inherited Cardiovascular Diseases; Arrhythmias; Cardiomyopathies; Congenital Heart Diseases; Other Appications
  • 4) By End User: Hospitals And Clinics; Diagnostic Laboratories; Academic And Research Institutes; Other End Users
  • Subsegments:
  • 1) By Single-Gene Panels: Ion Channel Gene Panels; Structural Heart Disease Gene Panels; Arrhythmia Gene Panels
  • 2) By Multi-Gene Panels: Cardiomyopathy Panels; Arrhythmia Panels; Congenital Heart Disease Panels
  • 3) By Whole Exome Sequencing Panels: Targeted Cardiovascular Exome Panels; Comprehensive Exome Panels; Research-Oriented Exome Panels
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Eurofins Scientific SE; Illumina Inc.; Actia Group; Invitae Corporation; Fulgent Genetics Inc.; GeneDx Inc.; Ambry Genetics Corporation; Helix OpCo Inc.; Centogene Gmbh; Blueprint Genetics Inc.; Strand Life Sciences Pvt. Ltd.; Genes2Me Pvt. Ltd.; BioAro Inc.; GENinCode Plc; Igenomix S.L.; Asper Biotech Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Cardiogenomics Testing Panels Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Cardiogenomics Testing Panels Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Cardiogenomics Testing Panels Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Cardiogenomics Testing Panels Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Personalized Genetic Risk Profiling
    • 4.2.2 Ai-Driven Diagnostic Tools
    • 4.2.3 Tele-Cardiology And Remote Monitoring
    • 4.2.4 Integration Of Multi-Gene Panels
    • 4.2.5 Advanced Bioinformatics Platforms

5. Cardiogenomics Testing Panels Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Diagnostic Laboratories
  • 5.3 Academic And Research Institutes
  • 5.4 Cardiology Centers
  • 5.5 Specialized Genetic Testing Centers

6. Cardiogenomics Testing Panels Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cardiogenomics Testing Panels Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Cardiogenomics Testing Panels PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Cardiogenomics Testing Panels Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Cardiogenomics Testing Panels Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Cardiogenomics Testing Panels Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cardiogenomics Testing Panels Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cardiogenomics Testing Panels Market Segmentation

  • 9.1. Global Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Gene Panels, Multi-Gene Panels, Whole Exome Sequencing Panels
  • 9.2. Global Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Next-Generation Sequencing, PCR-Based Testing, Microarray, Other Technologies
  • 9.3. Global Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Inherited Cardiovascular Diseases, Arrhythmias, Cardiomyopathies, Congenital Heart Diseases, Other Appications
  • 9.4. Global Cardiogenomics Testing Panels Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutes, Other End Users
  • 9.5. Global Cardiogenomics Testing Panels Market, Sub-Segmentation Of Single-Gene Panels, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Ion Channel Gene Panels, Structural Heart Disease Gene Panels, Arrhythmia Gene Panels
  • 9.6. Global Cardiogenomics Testing Panels Market, Sub-Segmentation Of Multi-Gene Panels, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cardiomyopathy Panels, Arrhythmia Panels, Congenital Heart Disease Panels
  • 9.7. Global Cardiogenomics Testing Panels Market, Sub-Segmentation Of Whole Exome Sequencing Panels, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Targeted Cardiovascular Exome Panels, Comprehensive Exome Panels, Research-Oriented Exome Panels

10. Cardiogenomics Testing Panels Market Regional And Country Analysis

  • 10.1. Global Cardiogenomics Testing Panels Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Cardiogenomics Testing Panels Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cardiogenomics Testing Panels Market

  • 11.1. Asia-Pacific Cardiogenomics Testing Panels Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cardiogenomics Testing Panels Market

  • 12.1. China Cardiogenomics Testing Panels Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cardiogenomics Testing Panels Market

  • 13.1. India Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cardiogenomics Testing Panels Market

  • 14.1. Japan Cardiogenomics Testing Panels Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cardiogenomics Testing Panels Market

  • 15.1. Australia Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cardiogenomics Testing Panels Market

  • 16.1. Indonesia Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cardiogenomics Testing Panels Market

  • 17.1. South Korea Cardiogenomics Testing Panels Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cardiogenomics Testing Panels Market

  • 18.1. Taiwan Cardiogenomics Testing Panels Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cardiogenomics Testing Panels Market

  • 19.1. South East Asia Cardiogenomics Testing Panels Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cardiogenomics Testing Panels Market

  • 20.1. Western Europe Cardiogenomics Testing Panels Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cardiogenomics Testing Panels Market

  • 21.1. UK Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cardiogenomics Testing Panels Market

  • 22.1. Germany Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cardiogenomics Testing Panels Market

  • 23.1. France Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cardiogenomics Testing Panels Market

  • 24.1. Italy Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cardiogenomics Testing Panels Market

  • 25.1. Spain Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cardiogenomics Testing Panels Market

  • 26.1. Eastern Europe Cardiogenomics Testing Panels Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cardiogenomics Testing Panels Market

  • 27.1. Russia Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cardiogenomics Testing Panels Market

  • 28.1. North America Cardiogenomics Testing Panels Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cardiogenomics Testing Panels Market

  • 29.1. USA Cardiogenomics Testing Panels Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cardiogenomics Testing Panels Market

  • 30.1. Canada Cardiogenomics Testing Panels Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cardiogenomics Testing Panels Market

  • 31.1. South America Cardiogenomics Testing Panels Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cardiogenomics Testing Panels Market

  • 32.1. Brazil Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cardiogenomics Testing Panels Market

  • 33.1. Middle East Cardiogenomics Testing Panels Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cardiogenomics Testing Panels Market

  • 34.1. Africa Cardiogenomics Testing Panels Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cardiogenomics Testing Panels Market Regulatory and Investment Landscape

36. Cardiogenomics Testing Panels Market Competitive Landscape And Company Profiles

  • 36.1. Cardiogenomics Testing Panels Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Cardiogenomics Testing Panels Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Cardiogenomics Testing Panels Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific, Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

37. Cardiogenomics Testing Panels Market Other Major And Innovative Companies

  • Illumina Inc., Actia Group, Invitae Corporation, Fulgent Genetics Inc., GeneDx Inc., Ambry Genetics Corporation, Helix OpCo Inc., Centogene Gmbh, Blueprint Genetics Inc., Strand Life Sciences Pvt. Ltd., Genes2Me Pvt. Ltd., BioAro Inc., GENinCode Plc, Igenomix S.L., Asper Biotech Ltd.

38. Global Cardiogenomics Testing Panels Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cardiogenomics Testing Panels Market

40. Cardiogenomics Testing Panels Market High Potential Countries, Segments and Strategies

  • 40.1 Cardiogenomics Testing Panels Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Cardiogenomics Testing Panels Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Cardiogenomics Testing Panels Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer